Pharmaceutical production: prospects of production reaching $4 billion in 2024
National pharmaceutical production is set to reach more than $4 billion by 2024, according to sector forecasts, announced Ali Aoun, Minister of Industry and Pharmaceutical Production, in Algiers on Sunday.Read more…
Novo Nordisk Algeria: export of 2.5 million insulin pens to Saudi Arabia
On Sunday 28 April, the pharmaceutical laboratory Novo Nordisk Algeria began exporting insulin pens to the Kingdom of Saudi Arabia. The launch of this operation was overseen by the Minister for Industry and Pharmaceutical Production, Ali Aoun, from the Novo Nordisk company’s industrial site in Boufarik (wilaya of Blida). Read more…
Pharmaceutical industry: Aoun announces a digital platform for investors
The Minister for Industry and Pharmaceutical Production, Ali Aoun, announced yesterday (Tuesday) in Constantine that studies will be launched from next May to develop the digital platform dedicated to investors in the pharmaceutical industry “to enable them to deal directly and remotely with the administration”.- Read more…
Industrie pharmaceutique : Aoun annonce une plateforme numérique pour les investisseurs
Le ministre de l’Industrie et de la Production pharmaceutique, Ali Aoun, a annoncé, hier mardi à Constantine, que des études seront entamées à partir du mois de mai prochain pour développer la plateforme numérique dédiée aux investisseurs dans l’industrie pharmaceutique «afin de leur permettre de traiter directement et à distance avec l’administration». Lire la suite
«L’Algérie peut devenir un véritable hub»
Mohamed Nibouche, expert en affaires pharmaceutiques, a mis en lumière l’importance cruciale du développement de l’industrie du vaccin pour l’Algérie et l’Afrique dans son ensemble. L’expert intervenait, hier, dans l’émission L’Invité de la rédaction, de la Chaîne 3 de la Radio nationale. Lire la suite…
Saidal s’apprête à produire localement des vaccins en Algérie
Le groupe Saidal s’apprête à produire localement des vaccins en Algérie, une annonce faite par son directeur général, Wassim Kouidri. Un accord a été signé entre Saidal et l’Institut Pasteur Algérie pour la production de certains vaccins importés. Le premier vaccin à être produit sera celui contre la grippe, prévu pour être sur le marché […]
Pharmaceutical industry: A target of $17 million in exports by 2024
The pharmaceutical industry has seen a real revival in recent years, underpinned by a solid, highly skilled business fabric that promises strong growth in terms of production and exports in the future. Read more…
Saïdal: laying of the foundation stone for a production site in Mostaganem
The Minister of Industry and Pharmaceutical Production, Ali Aoun, laid the foundation stone for a Saïdal Group manufacturing site in Mostaganem on Saturday, specializing in the production of ophthalmic medicines and veterinary products. Read more…
Saidal to relaunch production of penicillin and non-penicillin raw materials
State-owned pharmaceutical group Saidal will soon be relaunching production of penicillin and non-penicillin raw materials at the group’s Médéa site. Saidal will be supported in this operation by Indian partner Octavious Pharma.Read more…
Pharmaceutical industry: Towards a stronger partnership between Algeria and Tunisia
In the world of healthcare and the pharmaceutical industry, international collaboration is of crucial importance. It is in this context that the Algerian Minister of Industry and Pharmaceutical Production, Mr. Ali Aoun, recently paid a visit to Tunisia, where he was received by the Head of the Tunisian Government, Mr. Ahmed Hachani. Read more…
Locally produced pharmaceutical products: 70% of the national market covered
The Minister of Industry and Pharmaceutical Production, Ali Aoun, said on Monday that the national market coverage rate for locally manufactured pharmaceutical products was 68% and should reach 70%. Read more…
Saïdal: new business model will reduce import bill by $1.1 billion by 2026
Saïdal’s PGD, Wassim Kouidri, claimed that the new business model adopted by the state-owned group specializing in the manufacture of pharmaceutical products will reduce the drug import bill by $1.1 billion in 2026. Read more…
Saidal inaugurates Algeria’s first bioequivalence center
State-owned pharmaceutical group Saidal inaugurated Algeria’s first bioequivalence center in Algiers on Sunday, dubbed the “Equival Biocenter”, which will be tasked with carrying out studies to prove the efficacy and safety of generic drugs. Read more…
Gelatin capsule production: RayanOX to set up plant in Sidi Bel-Abbès
RayanOX, a medical gas manufacturer based mainly in Oran, intends to expand its activities in the near future and start producing gelatin capsules, with plans for a plant to be set up in Sidi Bel-Abbès, according to its director, Mohamed Amine Tazi. Read more…
Batna: Insulin crystal plant project
The insulin crystal production plant planned for the wilaya of Batna is “the only one of its kind in Africa”, emphasized the Minister of Industry and Pharmaceutical Production, Ali Aoun, yesterday, during an inspection visit to the site chosen in Cité Kechida (Batna) for the future Saïdal Group unit. Read more…
Production of neuropsychiatric drugs: Aoun inaugurates Groupe Santé in Tipasa
The Minister of Industry and Pharmaceutical Production, Ali Aoun, said on Tuesday in Koléa (Tipasa), that the new “Groupe Santé” for the production of neuropsychiatric drugs is “an important achievement” for the sector. Read more…
Sanofi and Algeria: An Innovative Partnership for Pharmaceutical Self-Sufficiency
At the heart of public health and industrial issues, the Minister of Industry and Pharmaceutical Production, Ali Aoun, recently held a crucial meeting with the executives of Sanofi laboratories. Read more…
Dr Kerrar: Algeria can become a major player in the pharmaceutical industry
The Vice-President of the Algerian Economic Renewal Council (CREA), Dr. Abdelouahed Kerrar, is firmly convinced that Algeria is on the right track to relaunching its economy and becoming a major player in the region, particularly, in the pharmaceutical industry. Read more…
Tarek Youssef Hosni, CEO of Jamjoom Pharma: “The support and facilities granted to us will enable us to rapidly put our investment into practice”.
The Saudi pharmaceutical group, Jamjoom Pharma, which has just invested in Algeria by buying a Sandoz factory with Vital Care, wants, through the voice of its CEO Tarek Hosni, to send positive messages of its projects in Algeria. Read more…
Tizi-Ouzou: export of a batch of antidiabetics to Libya
A first batch of 140,000 boxes of anti-diabetic tablets was exported on Tuesday by Novo nordisk Algeria to Libya, from its production site in Tizi-Ouzou, reports the APS agency. Read more…
AstraZeneca to manufacture five drugs in Algeria
On Tuesday March 5, AstraZeneca announced “an ambitious expansion and localization plan” that will see five of the international pharmaceutical company’s flagship drugs manufactured in Algeria over the next five years. Read more…
Vietnam and Algeria strengthen pharmaceutical cooperation
The Vietnamese Institute for Research and Treatment of Serious Diseases (Radiner) and the Algerian pharmaceutical group Saidal have just signed a cooperation agreement, under which the Vietnamese side will transfer to Algeria medicines and products to support the treatment of drug withdrawal and plant-based anticancer drugs. Read more